Plotted Points Statistics |
1-NAPHTHOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 58% | 25% | 64% | 30% |
>= Reporting Level | 53 | 50% | 32% | 46% | 33% |
Total | 61 | 51% | 31% | 47% | 31% |
Sample Statistics |
1-NAPHTHOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
2,6-DIETHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 94% | 24% | 99% | 12% |
Total | 58 | 94% | 24% | 99% | 12% |
Sample Statistics |
2,6-DIETHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 95% | Spiked |
Estimated Values | 8 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 3 | 5% | 3 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
BQS OBSP Determination: |
2-CHLORO-2,6-DIETHYLACETANILIDE |
SCHEDULE: 2033 , TESTIDCODE: 61618GCM39 |
Open Data Set |
Plotted Points Statistics |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 47 | 106% | 15% | 106% | 12% |
Total | 47 | 106% | 15% | 106% | 12% |
Sample Statistics |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 47 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 0 | 0% | 0 out of 47 |
Not Spiked | 135 | . | |
False Positives | 0 | 0% | 0 out of 135 |
BQS OBSP Determination: |
2-ETHYL-6-METHYLANILINE |
SCHEDULE: 2033 , TESTIDCODE: 61620GCM39 |
Open Data Set |
Plotted Points Statistics |
2-ETHYL-6-METHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 117% | 16% | 117% | 17% |
>= Reporting Level | 51 | 83% | 25% | 90% | 8% |
Total | 53 | 84% | 26% | 90% | 8% |
Sample Statistics |
2-ETHYL-6-METHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 98% | Spiked |
Estimated Values | 53 | 98% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 54 | . | |
False Negatives | 1 | 2% | 1 out of 54 |
Not Spiked | 128 | . | |
False Positives | 0 | 0% | 0 out of 128 |
Plotted Points Statistics |
3,4-DICHLOROANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 60 | 85% | 12% | 84% | 12% |
Total | 60 | 85% | 12% | 84% | 12% |
Sample Statistics |
3,4-DICHLOROANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 60 | 98% | Spiked |
Estimated Values | 60 | 98% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
3,5-DICHLOROANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 111% | 21% | 111% | 22% |
>= Reporting Level | 59 | 91% | 9% | 92% | 9% |
Total | 61 | 92% | 10% | 93% | 9% |
Sample Statistics |
3,5-DICHLOROANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 2 | 2% | 2 out of 121 |
BQS OBSP Determination: |
4-CHLORO-2-METHYLPHENOL |
SCHEDULE: 2033 , TESTIDCODE: 61633GCM39 |
Open Data Set |
Plotted Points Statistics |
4-CHLORO-2-METHYLPHENOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 66% | 12% | 66% | 12% |
Total | 61 | 66% | 12% | 66% | 12% |
Sample Statistics |
4-CHLORO-2-METHYLPHENOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
ACETOCHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 211% | 15% | 203% | 18% |
>= Reporting Level | 56 | 101% | 17% | 103% | 13% |
Total | 61 | 110% | 35% | 105% | 13% |
Sample Statistics |
ACETOCHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
ALACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 99% | 17% | 100% | 15% |
Total | 62 | 99% | 17% | 100% | 15% |
Sample Statistics |
ALACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
BQS OBSP Determination: |
ALPHA-ENDOSULFAN (ENDOSULFAN I) |
SCHEDULE: 2033 , TESTIDCODE: 34362GCM39 |
Open Data Set |
Plotted Points Statistics |
ALPHA-ENDOSULFAN (ENDOSULFAN I) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 90% | 18% | 87% | 16% |
Total | 61 | 90% | 18% | 87% | 16% |
Sample Statistics |
ALPHA-ENDOSULFAN (ENDOSULFAN I) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 3 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
ATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 101% | 14% | 102% | 11% |
Total | 61 | 101% | 14% | 102% | 11% |
Sample Statistics |
ATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 2 | 2% | 2 out of 121 |
Plotted Points Statistics |
AZINPHOS-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 24 | 93% | 20% | 95% | 21% |
>= Reporting Level | 37 | 79% | 18% | 80% | 18% |
Total | 61 | 84% | 20% | 85% | 22% |
Sample Statistics |
AZINPHOS-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
AZINPHOS-METHYL-OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 7 | 58% | 35% | 38% | 35% |
>= Reporting Level | 46 | 63% | 25% | 60% | 30% |
Total | 53 | 62% | 26% | 60% | 31% |
Sample Statistics |
AZINPHOS-METHYL-OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 100% | Spiked |
Estimated Values | 53 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 53 | . | |
False Negatives | 0 | 0% | 0 out of 53 |
Not Spiked | 129 | . | |
False Positives | 1 | 1% | 1 out of 129 |
Plotted Points Statistics |
BENFLURALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 80% | 13% | 80% | 13% |
Total | 61 | 80% | 13% | 80% | 13% |
Sample Statistics |
BENFLURALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
CARBARYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 28 | 112% | 21% | 110% | 20% |
>= Reporting Level | 33 | 89% | 21% | 88% | 21% |
Total | 61 | 99% | 24% | 100% | 23% |
Sample Statistics |
CARBARYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 1 | 1% | 1 out of 121 |
Plotted Points Statistics |
CARBOFURAN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 119% | 28% | 124% | 32% |
>= Reporting Level | 58 | 102% | 22% | 100% | 19% |
Total | 62 | 103% | 23% | 101% | 19% |
Sample Statistics |
CARBOFURAN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 62 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
CHLORPYRIFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 112% | 14% | 112% | 14% |
>= Reporting Level | 60 | 87% | 26% | 92% | 19% |
Total | 62 | 88% | 26% | 93% | 19% |
Sample Statistics |
CHLORPYRIFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 7 | 11% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
BQS OBSP Determination: |
CHLORPYRIFOS, OXYGEN ANALOG |
SCHEDULE: 2033 , TESTIDCODE: 61636GCM39 |
Open Data Set |
Plotted Points Statistics |
CHLORPYRIFOS, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 53% | 25% | 50% | 24% |
>= Reporting Level | 31 | 27% | 18% | 22% | 11% |
Total | 39 | 32% | 22% | 24% | 19% |
Sample Statistics |
CHLORPYRIFOS, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 64% | Spiked |
Estimated Values | 39 | 64% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 4 | 7% | Spiked |
Spiked | 61 | . | |
False Negatives | 18 | 30% | 18 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 118 |
Plotted Points Statistics |
CIS-PERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 69% | 17% | 66% | 15% |
Total | 61 | 69% | 17% | 66% | 15% |
Sample Statistics |
CIS-PERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
CIS-PROPICONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 96% | . | 96% | 0% |
>= Reporting Level | 21 | 114% | 34% | 109% | 31% |
Total | 22 | 113% | 34% | 108% | 31% |
Sample Statistics |
CIS-PROPICONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 22 | 100% | Spiked |
Estimated Values | 22 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 22 | . | |
False Negatives | 0 | 0% | 0 out of 22 |
Not Spiked | 160 | . | |
False Positives | 0 | 0% | 0 out of 160 |
Plotted Points Statistics |
CYANAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 95% | 24% | 94% | 22% |
Total | 61 | 95% | 24% | 94% | 22% |
Sample Statistics |
CYANAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 1 | 2% | 1 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
CYFLUTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 66% | 6% | 66% | 9% |
>= Reporting Level | 56 | 63% | 20% | 60% | 19% |
Total | 59 | 63% | 19% | 60% | 18% |
Sample Statistics |
CYFLUTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 100% | Spiked |
Estimated Values | 59 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 0 | 0% | 0 out of 59 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
CYHALOTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 78% | 6% | 78% | 6% |
>= Reporting Level | 59 | 45% | 17% | 46% | 21% |
Total | 61 | 46% | 18% | 48% | 21% |
Sample Statistics |
CYHALOTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 98% | Spiked |
Estimated Values | 61 | 98% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
CYPERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 62% | 5% | 62% | 5% |
>= Reporting Level | 59 | 65% | 17% | 64% | 16% |
Total | 61 | 65% | 16% | 64% | 16% |
Sample Statistics |
CYPERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
DACTHAL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 216% | 20% | 202% | 26% |
>= Reporting Level | 56 | 116% | 29% | 109% | 16% |
Total | 61 | 124% | 40% | 111% | 19% |
Sample Statistics |
DACTHAL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 13 | 21% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
BQS OBSP Determination: |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
SCHEDULE: 2033 , TESTIDCODE: 04040GCM35 |
Open Data Set |
Plotted Points Statistics |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 71% | 30% | 64% | 32% |
Total | 62 | 71% | 30% | 64% | 32% |
Sample Statistics |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) CIAT |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 62 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
DESULFINYLFIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 51 | 93% | 21% | 93% | 21% |
Total | 51 | 93% | 21% | 93% | 21% |
Sample Statistics |
DESULFINYLFIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 51 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 51 | . | |
False Negatives | 0 | 0% | 0 out of 51 |
Not Spiked | 131 | . | |
False Positives | 1 | 1% | 1 out of 131 |
BQS OBSP Determination: |
DESULFINYLFIPRONIL AMIDE |
SCHEDULE: 2033 , TESTIDCODE: 62169GCM29 |
Open Data Set |
Plotted Points Statistics |
DESULFINYLFIPRONIL AMIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 20 | 90% | 30% | 89% | 31% |
Total | 20 | 90% | 30% | 89% | 31% |
Sample Statistics |
DESULFINYLFIPRONIL AMIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 20 | 100% | Spiked |
Estimated Values | 19 | 95% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 20 | . | |
False Negatives | 0 | 0% | 0 out of 20 |
Not Spiked | 162 | . | |
False Positives | 0 | 0% | 0 out of 162 |
Plotted Points Statistics |
DIAZINON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 95% | 15% | 97% | 13% |
Total | 61 | 95% | 15% | 97% | 13% |
Sample Statistics |
DIAZINON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
BQS OBSP Determination: |
DIAZINON, OXYGEN ANALOG |
SCHEDULE: 2033 , TESTIDCODE: 61638GCM14 |
Open Data Set |
Plotted Points Statistics |
DIAZINON, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 75% | 26% | 70% | 28% |
Total | 58 | 75% | 26% | 70% | 28% |
Sample Statistics |
DIAZINON, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 85% | Spiked |
Estimated Values | 3 | 4% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 68 | . | |
False Negatives | 9 | 13% | 9 out of 68 |
Not Spiked | 114 | . | |
False Positives | 2 | 2% | 2 out of 114 |
BQS OBSP Determination: |
DICHLOROVOS (DICHLORVOS) |
SCHEDULE: 2033 , TESTIDCODE: 38775GCM39 |
Open Data Set |
Plotted Points Statistics |
DICHLOROVOS (DICHLORVOS) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 94% | . | 94% | 0% |
>= Reporting Level | 58 | 29% | 21% | 27% | 13% |
Total | 59 | 31% | 23% | 27% | 15% |
Sample Statistics |
DICHLOROVOS (DICHLORVOS) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 97% | Spiked |
Estimated Values | 59 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 2 | 3% | 2 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
DICROTOPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 18 | 45% | 15% | 44% | 16% |
>= Reporting Level | 39 | 27% | 13% | 21% | 13% |
Total | 57 | 32% | 16% | 29% | 17% |
Sample Statistics |
DICROTOPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 93% | Spiked |
Estimated Values | 57 | 93% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 4 | 7% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
DIELDRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 99% | 20% | 97% | 18% |
Total | 62 | 99% | 20% | 97% | 18% |
Sample Statistics |
DIELDRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
DIMETHOATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 43% | 17% | 37% | 18% |
Total | 61 | 43% | 17% | 37% | 18% |
Sample Statistics |
DIMETHOATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
DISULFOTON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 59% | . | 59% | 0% |
>= Reporting Level | 61 | 69% | 16% | 66% | 16% |
Total | 62 | 69% | 16% | 66% | 16% |
Sample Statistics |
DISULFOTON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 62 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
DISULFOTON SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 92% | 22% | 89% | 15% |
Total | 57 | 92% | 22% | 89% | 15% |
Sample Statistics |
DISULFOTON SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 57 | . | |
False Negatives | 0 | 0% | 0 out of 57 |
Not Spiked | 125 | . | |
False Positives | 0 | 0% | 0 out of 125 |
Plotted Points Statistics |
ENDOSULFAN SULFATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 92% | 16% | 92% | 14% |
Total | 62 | 92% | 16% | 92% | 14% |
Sample Statistics |
ENDOSULFAN SULFATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
EPTC |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 106% | 16% | 101% | 10% |
Total | 61 | 106% | 16% | 101% | 10% |
Sample Statistics |
EPTC |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 8 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 4 | 3% | 4 out of 121 |
Plotted Points Statistics |
ETHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 88% | 18% | 87% | 18% |
Total | 62 | 88% | 18% | 87% | 18% |
Sample Statistics |
ETHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
ETHION MONOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 20 | 90% | 19% | 85% | 19% |
Total | 20 | 90% | 19% | 85% | 19% |
Sample Statistics |
ETHION MONOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 20 | 100% | Spiked |
Estimated Values | 20 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 20 | . | |
False Negatives | 0 | 0% | 0 out of 20 |
Not Spiked | 162 | . | |
False Positives | 6 | 4% | 6 out of 162 |
Plotted Points Statistics |
ETHOPROPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 184% | 6% | 184% | 6% |
>= Reporting Level | 59 | 110% | 21% | 109% | 20% |
Total | 61 | 112% | 25% | 111% | 19% |
Sample Statistics |
ETHOPROPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
FENAMIPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 94% | 25% | 94% | 37% |
>= Reporting Level | 57 | 87% | 21% | 84% | 18% |
Total | 60 | 87% | 21% | 84% | 18% |
Sample Statistics |
FENAMIPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 60 | 98% | Spiked |
Estimated Values | 5 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 1 | 1% | 1 out of 121 |
Plotted Points Statistics |
FENAMIPHOS SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 86% | 27% | 86% | 33% |
>= Reporting Level | 50 | 84% | 23% | 85% | 27% |
Total | 61 | 84% | 23% | 86% | 27% |
Sample Statistics |
FENAMIPHOS SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 26 | 43% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
FENAMIPHOS SULFOXIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 13 | 45% | 31% | 38% | 25% |
>= Reporting Level | 38 | 31% | 15% | 29% | 14% |
Total | 51 | 34% | 21% | 31% | 16% |
Sample Statistics |
FENAMIPHOS SULFOXIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 51 | 85% | Spiked |
Estimated Values | 51 | 85% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 4 | 7% | Spiked |
Spiked | 61 | . | |
False Negatives | 5 | 8% | 5 out of 60 |
Not Spiked | 121 | . | |
False Positives | 3 | 3% | 3 out of 120 |
Plotted Points Statistics |
FIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 160% | 16% | 155% | 17% |
>= Reporting Level | 80 | 96% | 23% | 94% | 21% |
Total | 84 | 99% | 26% | 95% | 22% |
Sample Statistics |
FIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 84 | 100% | Spiked |
Estimated Values | 84 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 84 | . | |
False Negatives | 0 | 0% | 0 out of 84 |
Not Spiked | 98 | . | |
False Positives | 4 | 4% | 4 out of 98 |
Plotted Points Statistics |
FIPRONIL SULFIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 66 | 100% | 21% | 98% | 19% |
Total | 66 | 100% | 21% | 98% | 19% |
Sample Statistics |
FIPRONIL SULFIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 0 | 0% | 0 out of 66 |
Not Spiked | 116 | . | |
False Positives | 21 | 18% | 21 out of 116 |
Plotted Points Statistics |
FIPRONIL SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 64% | 9% | 67% | 8% |
>= Reporting Level | 62 | 74% | 19% | 69% | 20% |
Total | 66 | 73% | 19% | 68% | 20% |
Sample Statistics |
FIPRONIL SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 100% | Spiked |
Estimated Values | 9 | 14% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 66 | . | |
False Negatives | 0 | 0% | 0 out of 66 |
Not Spiked | 116 | . | |
False Positives | 19 | 16% | 19 out of 116 |
Plotted Points Statistics |
FONOFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 281% | 50% | 253% | 64% |
>= Reporting Level | 53 | 81% | 25% | 87% | 17% |
Total | 56 | 92% | 52% | 87% | 19% |
Sample Statistics |
FONOFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 90% | Spiked |
Estimated Values | 5 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 62 | . | |
False Negatives | 4 | 6% | 4 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
HEXAZINONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 116% | 11% | 116% | 12% |
>= Reporting Level | 60 | 72% | 19% | 71% | 16% |
Total | 62 | 73% | 20% | 71% | 18% |
Sample Statistics |
HEXAZINONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 6 | 10% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
IPRODIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 53 | 68% | 28% | 79% | 23% |
Total | 53 | 68% | 28% | 79% | 23% |
Sample Statistics |
IPRODIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 85% | Spiked |
Estimated Values | 53 | 85% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 9 | 15% | 9 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
ISOFENPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 100% | 22% | 101% | 17% |
Total | 61 | 100% | 22% | 101% | 17% |
Sample Statistics |
ISOFENPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
MALAOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 10 | 106% | 20% | 112% | 27% |
>= Reporting Level | 51 | 82% | 22% | 84% | 17% |
Total | 61 | 86% | 24% | 85% | 16% |
Sample Statistics |
MALAOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 17 | 28% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
MALATHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 95% | 26% | 98% | 19% |
Total | 58 | 95% | 26% | 98% | 19% |
Sample Statistics |
MALATHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 94% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 4 | 6% | 4 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
METALAXYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 98% | 16% | 97% | 16% |
Total | 62 | 98% | 16% | 97% | 16% |
Sample Statistics |
METALAXYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
BQS OBSP Determination: |
METHIDATHION (SUPRACIDE) |
SCHEDULE: 2033 , TESTIDCODE: 61598GCM39 |
Open Data Set |
Plotted Points Statistics |
METHIDATHION (SUPRACIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 159% | 18% | 159% | 18% |
>= Reporting Level | 59 | 90% | 19% | 90% | 18% |
Total | 61 | 92% | 22% | 91% | 17% |
Sample Statistics |
METHIDATHION (SUPRACIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
METOLACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 104% | 20% | 102% | 13% |
Total | 61 | 104% | 20% | 102% | 13% |
Sample Statistics |
METOLACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 1 | 1% | 1 out of 121 |
Plotted Points Statistics |
METRIBUZIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 86% | 20% | 82% | 20% |
Total | 62 | 86% | 20% | 82% | 20% |
Sample Statistics |
METRIBUZIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
MOLINATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 117% | 59% | 107% | 13% |
Total | 58 | 117% | 59% | 107% | 13% |
Sample Statistics |
MOLINATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 95% | Spiked |
Estimated Values | 5 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 5% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
MYCLOBUTANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 101% | 16% | 101% | 17% |
>= Reporting Level | 59 | 87% | 18% | 87% | 22% |
Total | 61 | 88% | 18% | 87% | 20% |
Sample Statistics |
MYCLOBUTANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 4 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
OXYFLUORFEN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 104% | 17% | 104% | 17% |
>= Reporting Level | 60 | 75% | 21% | 73% | 22% |
Total | 62 | 76% | 22% | 74% | 23% |
Sample Statistics |
OXYFLUORFEN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 5 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
PARAOXON-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 73% | 24% | 69% | 22% |
Total | 62 | 73% | 24% | 69% | 22% |
Sample Statistics |
PARAOXON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 62 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
PARATHION-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 177% | 33% | 167% | 35% |
>= Reporting Level | 60 | 87% | 21% | 85% | 18% |
Total | 64 | 92% | 31% | 86% | 18% |
Sample Statistics |
PARATHION-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 100% | Spiked |
Estimated Values | 4 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 64 | . | |
False Negatives | 0 | 0% | 0 out of 64 |
Not Spiked | 118 | . | |
False Positives | 0 | 0% | 0 out of 118 |
Plotted Points Statistics |
PENDIMETHALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 96% | 19% | 94% | 19% |
Total | 62 | 96% | 19% | 94% | 19% |
Sample Statistics |
PENDIMETHALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
PHORATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 84% | 4% | 86% | 4% |
>= Reporting Level | 57 | 76% | 16% | 77% | 19% |
Total | 61 | 77% | 15% | 78% | 18% |
Sample Statistics |
PHORATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 8 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
PHORATE OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 115% | 28% | 110% | 34% |
>= Reporting Level | 54 | 95% | 24% | 93% | 26% |
Total | 58 | 96% | 24% | 94% | 27% |
Sample Statistics |
PHORATE OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 100% | Spiked |
Estimated Values | 58 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 58 | . | |
False Negatives | 0 | 0% | 0 out of 58 |
Not Spiked | 124 | . | |
False Positives | 0 | 0% | 0 out of 124 |
Plotted Points Statistics |
PHOSMET (IMIDAN) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 16 | 84% | 43% | 92% | 58% |
>= Reporting Level | 25 | 39% | 19% | 33% | 21% |
Total | 41 | 56% | 37% | 46% | 24% |
Sample Statistics |
PHOSMET (IMIDAN) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 67% | Spiked |
Estimated Values | 41 | 67% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 8 | 13% | Spiked |
Spiked | 61 | . | |
False Negatives | 12 | 20% | 12 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 118 |
Plotted Points Statistics |
PHOSMET OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 38% | 20% | 34% | 19% |
>= Reporting Level | 27 | 69% | 52% | 58% | 50% |
Total | 36 | 61% | 48% | 48% | 45% |
Sample Statistics |
PHOSMET OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 71% | Spiked |
Estimated Values | 36 | 71% | Spiked |
Deleted Values | 15 | 8% | Spiked + Not Spiked |
Spiked, Censored | 2 | 4% | Spiked |
Spiked | 53 | . | |
False Negatives | 13 | 25% | 13 out of 51 |
Not Spiked | 129 | . | |
False Positives | 0 | 0% | 0 out of 116 |
Plotted Points Statistics |
PROMETON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 92% | 18% | 95% | 15% |
Total | 61 | 92% | 18% | 95% | 15% |
Sample Statistics |
PROMETON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 5 | 4% | 5 out of 121 |
Plotted Points Statistics |
PROMETRYN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 196% | 15% | 201% | 12% |
>= Reporting Level | 56 | 100% | 20% | 98% | 16% |
Total | 61 | 108% | 33% | 102% | 17% |
Sample Statistics |
PROMETRYN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 1 | 1% | 1 out of 121 |
Plotted Points Statistics |
PROPANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 113% | 21% | 116% | 24% |
Total | 61 | 113% | 21% | 116% | 24% |
Sample Statistics |
PROPANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
PROPARGITE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 114% | 14% | 118% | 15% |
>= Reporting Level | 58 | 85% | 21% | 83% | 19% |
Total | 62 | 87% | 21% | 84% | 23% |
Sample Statistics |
PROPARGITE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 7 | 11% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
BQS OBSP Determination: |
PROPYZAMIDE (PRONAMIDE) |
SCHEDULE: 2033 , TESTIDCODE: 82676GCM35 |
Open Data Set |
Plotted Points Statistics |
PROPYZAMIDE (PRONAMIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 101% | 20% | 102% | 17% |
Total | 61 | 101% | 20% | 102% | 17% |
Sample Statistics |
PROPYZAMIDE (PRONAMIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
SIMAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 100% | 16% | 100% | 14% |
Total | 62 | 100% | 16% | 100% | 14% |
Sample Statistics |
SIMAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 22 | 18% | 22 out of 120 |
Plotted Points Statistics |
TEBUCONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 57 | 55% | 16% | 54% | 12% |
Total | 57 | 55% | 16% | 54% | 12% |
Sample Statistics |
TEBUCONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 57 | 100% | Spiked |
Estimated Values | 2 | 4% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 57 | . | |
False Negatives | 0 | 0% | 0 out of 57 |
Not Spiked | 125 | . | |
False Positives | 0 | 0% | 0 out of 125 |
Plotted Points Statistics |
TEBUTHIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 132% | 41% | 128% | 38% |
Total | 62 | 132% | 41% | 128% | 38% |
Sample Statistics |
TEBUTHIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 100% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 62 | . | |
False Negatives | 0 | 0% | 0 out of 62 |
Not Spiked | 120 | . | |
False Positives | 0 | 0% | 0 out of 120 |
Plotted Points Statistics |
TEFLUTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 814% | 995% | 131% | 1214% |
>= Reporting Level | 56 | 150% | 371% | 63% | 13% |
Total | 61 | 204% | 475% | 64% | 14% |
Sample Statistics |
TEFLUTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 0 | 0% | 0 out of 121 |
Plotted Points Statistics |
TERBUFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 122% | 34% | 122% | 36% |
>= Reporting Level | 61 | 79% | 21% | 74% | 24% |
Total | 63 | 81% | 22% | 77% | 24% |
Sample Statistics |
TERBUFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 100% | Spiked |
Estimated Values | 4 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 63 | . | |
False Negatives | 0 | 0% | 0 out of 63 |
Not Spiked | 119 | . | |
False Positives | 0 | 0% | 0 out of 119 |
BQS OBSP Determination: |
TERBUFOS-O-ANALOGUE SULFONE |
SCHEDULE: 2033 , TESTIDCODE: 61674GCM39 |
Open Data Set |
Plotted Points Statistics |
TERBUFOS-O-ANALOGUE SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 98% | 22% | 106% | 31% |
>= Reporting Level | 17 | 90% | 26% | 92% | 25% |
Total | 20 | 91% | 25% | 93% | 27% |
Sample Statistics |
TERBUFOS-O-ANALOGUE SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 20 | 100% | Spiked |
Estimated Values | 6 | 30% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 20 | . | |
False Negatives | 0 | 0% | 0 out of 20 |
Not Spiked | 162 | . | |
False Positives | 0 | 0% | 0 out of 162 |
Plotted Points Statistics |
TERBUTHYLAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 61 | 103% | 15% | 102% | 13% |
Total | 61 | 103% | 15% | 102% | 13% |
Sample Statistics |
TERBUTHYLAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 1 | 1% | 1 out of 121 |
Plotted Points Statistics |
THIOBENCARB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 189% | . | 189% | 0% |
>= Reporting Level | 59 | 107% | 21% | 105% | 19% |
Total | 60 | 108% | 24% | 105% | 19% |
Sample Statistics |
THIOBENCARB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 60 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 2 | 2% | 2 out of 121 |
Plotted Points Statistics |
TRANS-PROPICONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 22 | 92% | 11% | 91% | 13% |
Total | 22 | 92% | 11% | 91% | 13% |
Sample Statistics |
TRANS-PROPICONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 22 | 100% | Spiked |
Estimated Values | 22 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 22 | . | |
False Negatives | 0 | 0% | 0 out of 22 |
Not Spiked | 160 | . | |
False Positives | 0 | 0% | 0 out of 160 |
BQS OBSP Determination: |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
SCHEDULE: 2033 , TESTIDCODE: 61610GCM39 |
Open Data Set |
Plotted Points Statistics |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 69% | 4% | 69% | 6% |
>= Reporting Level | 57 | 67% | 18% | 67% | 19% |
Total | 61 | 67% | 17% | 67% | 17% |
Sample Statistics |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 100% | Spiked |
Estimated Values | 61 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 61 |
Not Spiked | 121 | . | |
False Positives | 6 | 5% | 6 out of 121 |